|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$36,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$4,500
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-15
|
$349,322
|
$17,466
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$74,634
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$3,750
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$7,484
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
West Coast AIDS and Cancer Specimen Resource (ACSR)
|
5U01CA066529-18
|
$1,149,461
|
$574,731
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
Washington University Molecular Imaging Center
|
2P50CA094056-12
|
$1,428,925
|
$171,471
|
PIWNICA-WORMS, DAVID
|
WASHINGTON UNIVERSITY
|
|
|
Vitamin D and Non-Hodgkin Lymphoma Prognosis
|
1K07CA157580-01A1
|
$126,224
|
$126,224
|
Kelly, Jennifer
|
UNIVERSITY OF ROCHESTER
|
|
|
Viral Oncology Training Grant
|
5T32CA009111-35
|
$316,972
|
$63,394
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Outpatient Clinic File
|
ZIA CP010126-00580
|
$74,164
|
$7,416
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-22S1
|
$139,963
|
$1,400
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-22
|
$399,112
|
$3,991
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$273,342
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$4,491
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$8,399
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133-10416
|
$248,881
|
$37,332
|
Freedman, Daryl
|
DCEG (NCI)
|
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
5U01CA105492-09
|
$743,706
|
$245,423
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-26S1
|
$74,440
|
$744
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-26
|
$1,427,680
|
$14,277
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
$284,747
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S1
|
$49,948
|
$2,497
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S2
|
$74,872
|
$3,744
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-05
|
$1,565,163
|
$78,258
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-13
|
$1,150,000
|
$34,500
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Understanding T Cell Rapamycin Resistance
|
ZIABC011220
|
$236,816
|
$71,045
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
1UM1CA164973-01A1
|
$3,899,100
|
$389,910
|
KOLONEL, LAURENCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Tumor Cell Networks Center
|
5U54CA112967-08
|
$2,356,288
|
$518,383
|
Lauffenburger, Douglas
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
|
Trial of mesna to prevent doxorubicin-induced plasma protein oxidation and TNFa r
|
5R01CA153227-03
|
$187,979
|
$93,990
|
MOSCOW, JEFFREY
|
UNIVERSITY OF KENTUCKY
|
|
|
Transplant Models
|
ZIABC010957
|
$853,840
|
$298,844
|
Gress, Ronald
|
CCR (NCI)
|
|
|
Transplant cancer match
|
ZIA CP010176-10291
|
$23,528
|
$11,764
|
Engels, Eric
|
DCEG (NCI)
|
|
|
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
|
ZIABC010621
|
$589,742
|
$353,845
|
Bates, Susan
|
CCR (NCI)
|
|
|
Transcriptomic and Proteomic Approaches to Discovering Viral Causes for Human Hem
|
1R01CA170354-01
|
$349,040
|
$349,040
|
Chang, Yuan
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Transcriptional silencing by the BCL6 oncoprotein
|
5R01CA104348-08
|
$256,823
|
$256,823
|
MELNICK, ARI
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
|
Training In Tumor Virology
|
5T32CA115299-07
|
$321,587
|
$64,317
|
Robertson, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-24
|
$2,254,252
|
$1,127,126
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
2U10CA045809-24
|
$1,389,595
|
$55,584
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-13
|
$1,415,212
|
$127,369
|
Herschman, Harvey
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
|
The role of p63 and p73 in cancer
|
5R01CA093853-10
|
$305,188
|
$152,594
|
MOLL, UTE
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
The Role of NPM-ALK Signaling in Tumor Cell Metabolism
|
1F31CA171373-01
|
$32,419
|
$32,419
|
McDonnell, Scott
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
|
1R01CA157660-01A1
|
$329,363
|
$164,682
|
KLEIN, ULF
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Role of miRNA-mediated RNAI in the Biology of Cancer
|
ZIABC010612
|
$142,698
|
$28,540
|
Caplen, Natasha
|
CCR (NCI)
|
|
|
The role of miR-155 in cell cycle regulation and tumorigenesis
|
5F32CA139883-03
|
$53,942
|
$53,942
|
So, Alex
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
The Role of Methylthioadenosine Phosphorylase Loss in Tumorigenesis
|
5R01CA131024-04
|
$358,605
|
$358,605
|
KRUGER, WARREN
|
FOX CHASE CANCER CENTER
|
|
|
The Role of KIR and FcR Genotype in the Efficacy of mAb and IL2 Immunotherapy
|
1R01CA166105-01
|
$339,250
|
$67,850
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's Lymphoma
|
5R01CA139083-04
|
$310,019
|
$310,019
|
RUBENSTEIN, JAMES
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene
|
5K08CA158069-02
|
$167,400
|
$167,400
|
PHILIP, MARY
|
UNIVERSITY OF WASHINGTON
|
|
|
The Role of Fbxw7 in genetic instability and cancer
|
5R01CA116481-06
|
$345,303
|
$69,061
|
Mao, Jian-Hua
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
|
The role of deregulated protein synthesis control in Myc-induced tumorigenesis
|
5R01CA140456-04
|
$310,970
|
$310,970
|
RUGGERO, DAVIDE
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
The Role of ATM in Suppression of Lymphomas
|
5R01CA158073-02
|
$332,000
|
$332,000
|
Zha, Shan
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Total relevant funding to Non Hodgkins Lymphoma for this search: $119,470,587
|
